Beth Israel Deaconess Medical Center
Clinical trials sponsored by Beth Israel Deaconess Medical Center, explained in plain language.
-
Migraine drug ajovy put to the test for better sleep
Disease control TerminatedThis study looked at whether fremanezumab (Ajovy), an FDA-approved migraine prevention drug, can also improve sleep quality in people with migraine. Twenty-two adults with frequent migraines (10-25 headache days per month) received monthly injections for three months. Researchers…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 23, 2026 11:54 UTC
-
Microwave probe aims to clear cancer-blocked airways, but study halted early
Disease control TerminatedThis study tested a new microwave device used through a thin tube to destroy tumors blocking the main airways in people with lung cancer. Only 3 patients were enrolled before the study was stopped. The goal was to see if the device could safely and effectively open the airway.
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
Promising HS drug study halted early
Symptom relief TerminatedThis study tested whether deucravacitinib, an oral medication, could reduce painful bumps and abscesses in people with moderate-to-severe hidradenitis suppurativa (HS). It planned to enroll 30 adults but was terminated early after only 7 participants. The goal was to see if the d…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 22, 2026 12:09 UTC
-
Eye test may predict schizophrenia drug success
Symptom relief TerminatedThis study aimed to see if a simple eye scan could predict which people with early schizophrenia would benefit from a drug called sodium nitroprusside. The drug was given to reduce psychosis symptoms like delusions and hallucinations. Only one person enrolled before the study was…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 18, 2026 11:57 UTC
-
Diarrhea drug trial halted early: what we know
Symptom relief TerminatedThis study tested whether crofelemer, a drug that reduces fluid secretion in the gut, could improve stool consistency in adults with functional diarrhea. The trial was terminated early after enrolling only 17 participants. The main goal was to measure stool firmness after 4 weeks…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 15, 2026 19:05 UTC
-
Anesthesia drug study halted after just 3 patients
Knowledge-focused TerminatedThis study aimed to see if skipping a type of muscle relaxant during general anesthesia could lower the risk of serious lung complications in high-risk surgery patients. The trial was terminated early after enrolling only 3 participants, so no meaningful conclusions can be drawn.…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC
-
Tiny study explores better lung monitoring during surgery
Knowledge-focused TerminatedThis study looked at whether a special pressure measurement (esophageal pressure) can be used during surgeries where only one lung is ventilated. Six adults having non-cardiac surgery participated. Researchers compared the pressure readings to lung collapse images from a device c…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:10 UTC
-
New device measures skin stiffness to track lymphedema
Knowledge-focused TerminatedThis study tested a noninvasive device that measures skin elasticity in people with lymphedema, a condition causing swelling. Researchers aimed to better understand how the disease progresses and how surgery affects it. Only 7 adults from one hospital took part, and the study was…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:07 UTC
-
New blood pressure cuff could replace needles for High-Risk C-Sections
Knowledge-focused TerminatedThis study tested a non-invasive blood pressure monitor (CNAP) against the standard invasive method (using a needle in the artery) in 20 pregnant women with placenta accreta undergoing scheduled C-sections. The goal was to see if the gentler method gives equally accurate readings…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC